MYOPIA FB Twitter LinkedIn


Myopia, also known as 'short-sightedness' or 'near-sightedness', causes people to have difficulty seeing distant objects clearly. It is estimated that half the world’s population will be myopic by 2050.1 Growing levels of high myopia are increasing the risks of serious eye conditions, which may lead to permanent blindness.

Myopia Program

The onset of myopia at an early age brings with it the likelihood of life-long eye care, there is a significantly increased risk of serious ocular health problems with high myopia, which can lead to vision loss and blindness. It is projected that almost 1 billion people will have high myopia by 2050.1

With our strategic focus on myopia, Brien Holden Vision Institute is conducting a suite of projects in this area, including: collaborating on design and assessment of community interventions in clinical trials to control myopia; furthering our understanding of the mechanisms related to onset and progression of myopia; and developing tools to aid eye care practitioners in myopia management.

Our translational research platforms are developing novel optical products to manage myopia, in particular contact lenses and spectacles.

Related Stories



With the rapidly changing landscape with respect to ‘standard of care’ for management of myopia, there is a need for tools to aid practitioners and better inform the public, community and relevant groups.

We are using our research platforms, collaboration networks and market insights to develop a range of tools such as, for example, clinical e-learning modules to help eye care practitioners identify candidates at risk, and empower them with the skills to better manage progressive myopia for patients.

Find out more:


In 2017, we developed a new evidence-based myopia ‘calculator’ to support clinicians in communicating and educating patients in managing myopia appropriately.

The free, simple to use web-based tool runs on a range of electronic devices and merges individual patient information with different optical and pharmacological treatment options to illustrate the impact on their future level of myopia.

Access the calculator here:



This project will utilise data on high myopia and myopia in school-aged children produced through research conducted at our centre and with collaborating partners, to further improve our understanding of myopia.



An estimated 1.22 billion people are blind or vision impaired globally because they can’t access the same kind of care. Over 100 million of that is due to uncorrected myopia.

This is largely due to a lack of facilities, infrastructure and the equipment necessary to provide eye care services, as well as a shortage of practitioners and other skilled personnel, especially in rural and remote areas in developing communities.

Our strategy to develop sustainable eye care services is based on the establishment of environments that enable trained eye care professional to provide much needed services locally. Find out more.

Our children need healthy eyes and vision to develop and thrive. Yet, millions of our children are vision impaired because they do not have access to eye care and treatment, having long-lasting, negative consequences for many of them. The majority of this vision impairment is due to uncorrected myopia.

Our Children’s Vision is a call to action, initiated by Brien Holden Vision Institute and Vision For Life – Essilor, where partners are ensuring that effective, inclusive, sustainable eye health initiatives for children and adolescents are part of appropriate health programs and are integrated into regional, national and global education and health policies and practices for children. Find out more.


The International Myopia Institute (IMI) has brought together leading researchers, clinicians, educators and policy makers, to address the growing prevalence of myopia, the risks to vision and how clinicians should best manage myopia, while further advancing myopia research.

Brien Holden Vision Institute hosts the secretariat for the IMI. Find out more at:


In March 2015, the World Health Organization (WHO) and Brien Holden Vision Institute held a joint Global Scientific Meeting on Myopia at the Brien Holden Vision Institute in Sydney, Australia, to address the public health issue of myopia, the classification of myopia, evidence for treatments, and the need to take action.

The meeting, which brought together myopia experts from each WHO region, was the culmination of a joint effort between the Brien Holden Vision Institute and the WHO, with the support of the former Australian Minister for Health, Mr Peter Dutton, and funded by the Vision Cooperative Research Centre.

In October, 2016, the WHO released a report "The impact of myopia and high myopia", based on the meeting. To read the report click here.


  1. Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, Wong TY, Naduvilath TJ, Resnikoff S, Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050, Ophthalmology, May 2016 Volume 123, Issue 5, Pages 1036–1042.